glp 1 drugs and alzheimer's Frontiers Glucagon like peptide-1 (GLP-1) likes
Description
Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML
They are most prevalent during or shortly after dose escalation and decrease afterwards
Accessed May 2018
Rosenstock J, Ferrannini E
Weve seen countless examples of medications that caused problems in animal studies but were perfectly safe in humansand vice versa
